This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on July 6, 2024.

Return to the list of Patented Medicine Litigation page.

---

---

Diltiazem

TIAZAC, TIAZAC XC – Biovail Pharmaceuticals Canada (NOC Search)

Patents:

• 2111085: SANDOZ, , RHOXALPHARMA, APOTEX
• 2242224: COBALT, SANDOZ, APOTEX
• 2307547: COBALT

Unknown/Other

• Other – T-60-02

APOTEX

• PM(NOC) – T-1262-05

COBALT

• Appeal – A-221-13 (2014 FCA 50) – A-434-13
• PM(NOC) – A-222-13 – T-1805-12 (2013 FC 1254)

RHOXALPHARMA

• PM(NOC) – T-472-02

SANDOZ

• Appeal – A-556-05
• Infringement – T-1245-06 – T-214-06

---

Return to the Patented Medicine Litigation page.